Literature DB >> 11740055

Sporadic type composite pheochromocytoma with neuroblastoma: clinicomorphologic, DNA content and ret gene analysis.

F A Candanedo-González1, I Alvarado-Cabrero, A Gamboa-Domínguez, A Cérbulo-Vázquez, R López-Romero, L Bornstein-Quevedo, M Salcedo-Vargas.   

Abstract

Composite pheochromocytomas (CP) account for only 3% of all pheochromocytomas. We analyzed the clinical, immunohistochemical, ultrastructural, DNA content, and 634 ret mutation features in a 56-year-old Mexican woman with CP localized in the right adrenal gland and associated to a blood pressure of 140/90 mmHg. Clinical symptoms were absent after surgery. The tumor showed pheochromocytoma and neuroblastoma components. This dual phenotype was supported by light microscopy and corroborated by immunohistochemistry and ultrastructural findings. Flow cytometric analysis showed that both components were diploid. A genetic mutational analysis of the ret oncogene in exon 11 showed no 634 mutation. This case demonstrates the indolent behavior of neuroblastoma associated to a sporadic-type CP in an adult patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740055     DOI: 10.1385/ep:12:3:343

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  19 in total

Review 1.  Divergent differentiation in neuroendocrine tumors of the adrenal gland.

Authors:  A S Tischler
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

2.  Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin.

Authors:  T Perrone; R K Sibley; J Rosai
Journal:  Am J Surg Pathol       Date:  1985-01       Impact factor: 6.394

3.  Combined spindle cell sarcoma/phaeochromocytoma of the adrenal.

Authors:  H R Harach; P Laidler
Journal:  Histopathology       Date:  1993-12       Impact factor: 5.087

Review 4.  Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.

Authors:  C Eng; L M Mulligan
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

5.  Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.

Authors:  H M Brown; R A Komorowski; S D Wilson; M J Demeure; Y R Zhu
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

6.  Flow cytometry DNA ploidy analysis and catecholamine secretion profiles in neuroblastoma.

Authors:  C R Abramowsky; S R Taylor; A H Anton; A I Berk; M Roederer; R F Murphy
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

7.  Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A.

Authors:  R F Gagel; G J Cote; M J Martins Bugalho; A E Boyd; T Cummings; H Goepfert; D B Evans; A Cangir; S Khorana; P N Schultz
Journal:  J Intern Med       Date:  1995-10       Impact factor: 8.989

8.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

9.  A case of recurrent malignant pheochromocytoma complicated by watery diarrhea, hypokalemia, achlorhydria syndrome.

Authors:  K Nigawara; T Suzuki; H Tazawa; T Funyu; S Yagihashi; K Yamaya; Y Terayama; K Yamaguchi
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

10.  Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.

Authors:  R McMahon; L M Mulligan; C S Healey; S J Payne; M Ponder; M A Ferguson-Smith; D E Barton; B A Ponder
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

View more
  5 in total

1.  Radiological and pathological findings of a metastatic composite paraganglioma with neuroblastoma in a man: a case report.

Authors:  Florian R Fritzsche; Peter K Bode; Sonja Koch; Thomas Frauenfelder
Journal:  J Med Case Rep       Date:  2010-11-19

2.  Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene.

Authors:  G P Bernini; A Moretti; M Mannelli; T Ercolino; M Bardini; D Caramella; C Taurino; A Salvetti
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

3.  Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma.

Authors:  Keiji Tasaka; Hiroo Ueno; Kai Yamasaki; Takahiro Okuno; Tomoya Isobe; Shunsuke Kimura; Katsutsugu Umeda; Junichi Hara; Seishi Ogawa; Junko Takita
Journal:  Cancer Sci       Date:  2022-02-16       Impact factor: 6.716

Review 4.  Composite phaeochromocytomas-a systematic review of published literature.

Authors:  K Dhanasekar; V Visakan; F Tahir; S P Balasubramanian
Journal:  Langenbecks Arch Surg       Date:  2021-03-02       Impact factor: 2.895

5.  Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.

Authors:  Lily Tran; Carrie Fitzpatrick; Susan L Cohn; Peter Pytel
Journal:  Virchows Arch       Date:  2017-09-01       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.